 Home > Popular Keywords > Keyword List K > kodiak pharma

kodiak pharma

View news and stories of kodiak pharma. Echemi provides huge amount of kodiak pharma information to support you.

The new anti-tumor drug introduced by Lee's Big Pharma has been approved for marketing

 Time of Update: 2022-05-18

From https:// Good News Group's anti-tumor drug for the treatment of advanced Hodgkin's lymphoma - Natulan® has been accepted by the NMPA, and the application for priority review will be submitted in May.
Lingke Pharma LNK01004 was approved for clinical use in the treatment of psoriasis in China

 Time of Update: 2022-05-17

LNK01004 showed good efficacy and safety in animal experiments .
【2022 ASCO】Ascentage Pharma selected for seven clinical progresses, and multiple pipelines go hand in hand

 Time of Update: 2022-05-15

>. Zhai Yifan, Chief Medical Officer of Ascentage Pharma, said: "This will be the fifth consecutive year Ascentage Pharma has appeared at ASCO, and I am delighted to showcase our multiple clinical progress, which further
Hengrui Pharma Appoints New General Manager to Enhance Enterprise Transformation Momentum

 Time of Update: 2022-05-13

in a critical period of transformation, and the adjustment of executive personnel for many times is obviously a necessary measure to stimulate the vitality of the organization, strengthen operation management, and increase the momentum of enterprise
TOP5 neuroleptic drug Lonno Pharma risperidone oral solution is about to be approved

 Time of Update: 2022-05-02

　　Recently, Shandong Longnuo Pharmaceutical's 4 types of generic risperidone oral solution has entered
Huadong Medicine's wholly-owned subsidiary signed an equity investment agreement with Heidelberg Pharma

 Time of Update: 2022-05-02

On February 28, Huadong Medicine announced that its wholly-owned subsidiary signed an equity investment agreement
Ono Pharma's VelexbruBTK inhibitor approved in Taiwan for the treatment of adult patients with PCNSL

 Time of Update: 2022-05-02

Ono Pharmaceutical recently announced that the company's BTK inhibitor Velexbru (tirabrutinib hydrochloride, 80mg tablet
A large number of pharmaceutical companies such as Tofflon and Buchang Pharma issued favorable announcements

 Time of Update: 2022-05-01

Buchang Pharmaceutical's Wholly-owned Subsidiary Obtained a Notice of Approval for Drug Clinical Trials On March 1, Buchang Pharmaceutical issued an announcement that Shandong Danhong Pharmaceutical Co.
Euho Pharma's global multicenter Phase I clinical study of YH002 (OX40 antibody) combined

 Time of Update: 2022-04-30

BEIJING, March 8, 2022 /PRNewswire/ -- Euho Pharma, a wholly-owned subsidiary of Biositu, today announced an international multi-center ( MRCT) Phase I clinical study (No.
Tide Pharma's first-class innovative drug for pneumoconiosis was approved for clinical use

 Time of Update: 2022-04-30

Ted Pharmaceuticals revealed that TDI01 has completed Phase I clinical trials in the United States with good safety, and is currently conducting bridging trials in China .
Ascentage Pharma Announces Six Recent Preclinical Advances to be Presented at the 2022 American Association for Cancer Research (AACR) Annual Meeting

 Time of Update: 2022-04-30

62em; font-family:"Arial"; color:black; margin:0in; } Suzhou, China and Rockville, Maryland, USA, March 9, 2022 /PRNewswire/ -- Ascentage, a leading biopharmaceutical company dedicated to developing innovative medicines in the therapeutic areas of oncology, hepatitis B and aging-related diseases Pharma (6855.
Hansoh Pharma's innovative drug revenue will rise by 169% in 2021!

 Time of Update: 2022-04-28

of 14. 3%; profit was 2. 713 billion yuan, a year-on-year increase of 5. 6%; R&D investment was 1. 797 billion yuan, a year-on-year increase of 43. 5%, accounting for 18. 1% of revenue
Fosun Pharma, Huahai Pharma Receive MMP License to Produce Generic Drugs of Novel Coronavirus Oral Drug Nematevir

 Time of Update: 2022-04-26

On March 18, Fosun Pharma and Huahai Pharmaceutical announced separately that the MPP (Medicine Patent Pool Organization) granted them the use of related patents and know-how to produce generic
Ascentage Pharma Completes First Patient Dosing in China's Key Registration Phase II Clinical Trial

 Time of Update: 2022-04-26

lymphocytic leukemia/small lymphocytic lymphoma (R/R CLL/SLL) has completed the first patient dosing, and is the second entry in the world Registered clinical stage Bcl-2 inhibitor . APG2575CC201
Bruker acquires Pharma PAT Software and biopharmaceutical manufacturing automation company

 Time of Update: 2022-04-26

scientific instrumentation supplier Bruker has acquired Optimal Industrial automation and Technologies, a UK-based specialist in pharmaceutical and biopharmaceutical process analysis technology, pharmaceutical manufacturing automation and quality assurance software, and systems integration, the company said a few days ago .
Boshengji Pharma's CAR-T therapy for neuroblastoma has been granted orphan drug designation by the FDA

 Time of Update: 2022-04-25

According to the press release, Boshengji Medicine intends to develop TAA06 injection for the treatment of neuroblastoma .
Biositu/Yuhe Pharma Announces the Completion of the First Patient Dosing in the Australian Phase I

 Time of Update: 2022-04-25

Yimaike's recent hot reports ★Two "blockbusters", marketed ADC drugs are leading the way ★Biosetu/Youhe international clinical research has entered a new journey: 4-1BB monoclonal antibody completed the first
Fosun Pharma achieves steady growth in 2021

 Time of Update: 2022-04-23

and quality system certification of YaoPharma, Guilin Nanyao, Wanbang Pharmaceutical, etc. , Fosun Pharma accelerated the overseas quality system certification of domestic production lines, laying a solid foundation for domestic preparations
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Receives U.S. FDA Approval for Rare Disease in Children for the Treatment of Neuroblastoma

 Time of Update: 2022-04-23

with high-risk disease have disease-free survival (EFS) of less than 50% and poor prognosis . Relapsed or refractory neuroblastoma is extremely difficult to cure, and there is no standard treatment
Two innovative drugs from Hansoh Pharma launched clinical trials on the same day

 Time of Update: 2022-04-21

Clinical application of innovative drug projects of Hansoh Pharma in the past 5 years*Only the first declaration is countedFrom: Insight database (http://db.

Related Keywords

kodiak sciences kodiak biosciences inc kodiak sciences inc am pharma kingston pharma alector pharma pharma nutraceuticals pharma market

Go to Page

Hot Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

ketel one flavors(256)

kainic acid(173)

kepler business search(267)

klotho supplement(252)

k119 tools(278)

kurbo health(261)

kell antigen(255)

kayexalate powder(275)

kilz primer dry time(254)

kinetex flooring(255)

What's trending

Top Keywords

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

kodiak pharma

Related Tags

Related Keywords